Found: 8
Select item for more details and to access through your institution.
Low frequency of community-acquired bacterial co-infection in patients hospitalized for COVID-19 based on clinical, radiological and microbiological criteria: a retrospective cohort study.
- Published in:
- Antimicrobial Resistance & Infection Control, 2021, v. 10, n. 1, p. 1, doi. 10.1186/s13756-021-01024-4
- By:
- Publication type:
- Article
TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study).
- Published in:
- European Journal of Haematology, 2021, v. 107, n. 3, p. 364, doi. 10.1111/ejh.13674
- By:
- Publication type:
- Article
The pharmacotherapy team: A novel strategy to improve appropriate in‐hospital prescribing using a participatory intervention action method.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 2, p. 565, doi. 10.1111/bcp.14418
- By:
- Publication type:
- Article
Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
- Published in:
- International Journal of Clinical Pharmacy, 2022, v. 44, n. 2, p. 557, doi. 10.1007/s11096-022-01379-7
- By:
- Publication type:
- Article
Evaluation of the concurrent use of potassium-influencing drugs as risk factors for the development of hyperkalemia.
- Published in:
- International Journal of Clinical Pharmacy, 2013, v. 35, n. 6, p. 1099, doi. 10.1007/s11096-013-9830-8
- By:
- Publication type:
- Article
Prescribing errors in post - COVID-19 patients: prevalence, severity, and risk factors in patients visiting a post - COVID-19 outpatient clinic.
- Published in:
- BMC Emergency Medicine, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12873-022-00588-7
- By:
- Publication type:
- Article
Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 1, p. 163, doi. 10.3390/pharmaceutics15010163
- By:
- Publication type:
- Article